BlueRock Therapeutics

Business Services · Massachusetts, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

238 Main St Ste 3, Cambridge, Massachuse...

Phone Number

(857) 299-7589

Revenue

$42.3 Million

Industry

Business Services Research & Development
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
3
1
5
1
2

About BlueRock Therapeutics

BlueRock Therapeutics, a wholly owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics' cell+gene platform harnesses the power of cells for new medicines across neurology, cardiology and immunology indications. BlueRock Therapeutics' cell differentiation technology recapitulates the cell's developmental biology to produce authentic cell therapies, which are further engineered for additional function. Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. BlueRock's culture is defined by scientific innovation, highest ethical standards and an urgency to bring transformative treatments to all who would benefit.Explore more
BlueRock Therapeutics's Social MediaPopular SearchesBluerock Therapeutics LLCBlueRock TherapeuticsBlueRock Therapeutics LPBlueRockBlueRock Therapeutics toSIC Code 87,873NAICS Code 54,541Show more

BlueRock Therapeutics Org Chart

Seth Ettenberg, President & Chief Executive Officer at BlueRock Therapeutics
United States flag for contact location.

President & Chief Executive Officer

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
Craig Beasley, Chief Technology Officer at BlueRock Therapeutics
United States flag for contact location.

Chief Technology Officer

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
OM
United States flag for contact location.

Board Member Chief Financial Officer, Bayer P...

PhoneEmail
AR
United States flag for contact location.

Chief Medical Officer

PhoneEmail
RM
United States flag for contact location.

Chief People Officer

PhoneEmail
Petter Veiby, Chief Medical Officer at BlueRock Therapeutics
United States flag for contact location.

Chief Medical Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
LV
United States flag for contact location.

Senior VP, Clinical Development & Biometrics

PhoneEmail
PJ
United States flag for contact location.

Senior VP, Technical Development Strategy

PhoneEmail
MJ
United States flag for contact location.

Senior VP, Quality Assurance

PhoneEmail
JG
United States flag for contact location.

Vice President, Engineering & Msat

PhoneEmail
YW
United States flag for contact location.

Vice President, Head of Biometrics

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is BlueRock Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to BlueRock Therapeutics

Compare insights from companies similar to BlueRock Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

BlueRock Therapeutics

$42.3M
51-200
Private
-
2016
Seth Ettenberg, President & Chief Executive Officer at BlueRock Therapeutics
Seth EttenbergPresident & CEO
$50.1M
51-200
Private
$333.9M
2009
Michael Blue, President & Chief Executive Officer at HistoSonics
Michael BluePresident & CEO
$30.2M
51-200
Public
$218M
2014
Chen Schor, President & Chief Executive Officer at Adicet Bio
Chen SchorPresident & CEO
$10.3M
51-200
Public
$398M
2018
<$5M
51-200
Private
-
2008
RS
Rajasekar SeetharamanDirector, STEM Cell Lab Operations
<$5M
51-200
Private
$100M
1998
SF
Sheila FramePresident & Head of Business (US)
<$5M
51-200
Public
$20M
2014
LT
Liane TeplitskyChief Operating Officer
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

BlueRock Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

BlueRock Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BlueRock Therapeutics.

BlueRock Therapeutics Tech Stack

A closer look at the technologies used by BlueRock Therapeutics

Most Recent Scoops

Left Company
Executive Move
Executive Moves, Left Company
Open Position
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
See more scoops

BlueRock Therapeutics News & Media

Read more news

Top Business Services Companies

Frequently Asked Questions Regarding BlueRock Therapeutics

What is BlueRock Therapeutics's official website?
BlueRock Therapeutics's official website is www.bluerocktx.com
What is BlueRock Therapeutics's Revenue?
BlueRock Therapeutics's revenue is $42.3 Million
What is BlueRock Therapeutics's SIC code?
BlueRock Therapeutics's SIC: 87,873
What is BlueRock Therapeutics's NAICS code?
BlueRock Therapeutics's NAICS: 54,541
How many employees does BlueRock Therapeutics have?
BlueRock Therapeutics has 51-200 employees
What industry does BlueRock Therapeutics belong to?
BlueRock Therapeutics is in the industry of: Business Services, Research & Development
What is BlueRock Therapeutics competition?
BlueRock Therapeutics top competitors include: HistoSonics, Adicet Bio, Gamida Cell, Tscan Therapeutics
What companies has BlueRock Therapeutics acquired?
BlueRock Therapeutics has acquired the companies: Bayer Pharmaceuticals, Monsanto, Delta & Pine Land, De Ruiter Seeds
What technology does BlueRock Therapeutics use?
Some of the popular technologies that BlueRock Therapeutics uses are: Freshservice, Zingfit, DocuSign, WordPress.org
Who is the CFO of BlueRock Therapeutics?
BlueRock Therapeutics's CFO is Olivier Mauroy-Bressier
Who is the CTO of BlueRock Therapeutics?
BlueRock Therapeutics's CTO is Craig Beasley
How do I contact BlueRock Therapeutics?
BlueRock Therapeutics contact info: Phone number: (857) 299-7589 Website: www.bluerocktx.com
What does BlueRock Therapeutics do?

BlueRock Therapeutics, a wholly owned and independently operated subsidiary of Bayer AG, is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics' cell+gene platform harnesses the power of cells for new medicines across neurology, cardiology and immunology indicati... ons. BlueRock Therapeutics' cell differentiation technology recapitulates the cell's developmental biology to produce authentic cell therapies, which are further engineered for additional function. Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. BlueRock's culture is defined by scientific innovation, highest ethical standards and an urgency to bring transformative treatments to all who would benefit.Read More

What are BlueRock Therapeutics social media links?
BlueRock Therapeutics Linkedin page BlueRock Therapeutics Twitter page BlueRock Therapeutics Facebook page
Is BlueRock Therapeutics a public company?
BlueRock Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about BlueRock Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.